Recent recognition by CMS LCD in favour of Helicoll
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
Helicoll® is a bioengineered high purity Type-I collagen (>97% pure) forming an acellular skin substitute construct that is highly bioactive, cell conducive, and supportive towards enhancing tissue generation for wound management. Helicoll® is an acellular dermal replacement product and is within the definition of a bioengineered skin substitute. It provides a framework that promotes the regeneration of blood vessels and supports biologic cell migration due to the resorbable properties of Helicoll®. Treatment course typically involves 1 to 4 applications.
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
Collagen is an abundant component in the human body and plays a fundamental role in the integrity and function of various tissues, including skin……
Helicoll biological skin substitute product has received an Innovative Technology contract from Vizient, Inc., the largest member-driven healthcare performance…